• 名称: HCC1599(人乳腺原发性导管癌)
  • 货号: CBP60415
  • 浏览次数: 213
  • 已销售数量:0件
  • 评论信息
  • 购买数量:  购买数量不能低于最少订购数量!

购买 询价 收藏 QQ交流 好友推荐

CBP60415
I. General information 
Synonyms: HCC1599
Background: The HCC1599 breast cancer cell line was initiated on March 28, 1995, and took 10 months to establish.
Species: Homo sapiens, human
Tissue: mammary gland; breast/duct
Disease: TNM stage IIIA, grade 3, primary ductal carcinoma
Gender: female,44 years adult, Caucasian, White
Morphology: epithelial
Growth Mode: suspension, multicell aggregates
Doubling Time: N/A
DNA Profile: Amelogenin: X
CSF1PO: 12
D13S317: 11
D16S539: 12,13
D5S818: 12
D7S820: 10,11
THO1: 9.3
TPOX: 8
vWA: 17
Cobioer’s Cell Line Authentication Service
Culture Medium: RPMI1640+20%FBS
We strongly suggest to purchase the complete medium from Cobioer.
Cryopreservation medium: 90%FBS+10%DMSO
Antigen Expression: N/A
Receptor Expression: estrogen receptor, negative
progesterone receptor, negative
Oncogene: her2/neu -, p53 -
Genes Expressed: Epithelial glycoprotein 2 [EGP2]; cytokeratin 19
Cellular Products: Epithelial glycoprotein 2 [EGP2]; cytokeratin 19
Tumor Formation: N/A
Comments: The tumor was classified as a TNM stage IIIA, grade 3, invasive ductal carcinoma. Information regarding lymph node metastasis is not available.
The cells are poorly differentiated.
The cells are negative for expression of Her2-neu and for expression of p53.
The cells are negative for expression of estrogen receptor (ER) and for expression of progesterone receptor (PR).
HCC1599 is positive for the epithelial cell specific marker Epithelial Glycoprotein 2 (EGP2), and for cytokeratin 19.
An EBV-transformed lymphoblastoid cell line (HCC1599 BL) from the same patient is available as ATCC CRL-2332.
For more information, please contact Cobioer (4008-750-250).

关键词: